Asset
Fosdesdenosine Sipalabenamide
NuCana plc American Depositary Share
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03829254 | phase1_2 | recruiting | 2019-06-17 | 2026-08-01 | NuCana plc | A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma |
FDA applications (0)
This company has no applications containing this asset.